No question about it: Express Scripts, the country's largest pharmacy benefit manager, just took a big hit. Shares are down about 20% since some unmistakably pessimistic language filling a recent earnings release. But is this really a reason to jump ship? In this video, Motley Fool health-care analyst Brenton Flynn outlines a trio of trends that support the bull argument for Express Scripts longer term.
Free Article
You're reading a free article with opinions that may differ from The Motley Fool's Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.